Do calcium-channel blockers increase breast cancer risk?
被引:0
|
作者:
Ange Wang
论文数: 0引用数: 0
h-index: 0
机构:Stanford University School of Medicine,Department of Medicine
Ange Wang
JoAnn E. Manson
论文数: 0引用数: 0
h-index: 0
机构:Stanford University School of Medicine,Department of Medicine
JoAnn E. Manson
机构:
[1] Stanford University School of Medicine,Department of Medicine
[2] Brigham and Women's Hospital,Division of Preventive Medicine
[3] Harvard Medical School,undefined
来源:
Nature Reviews Cardiology
|
2013年
/
10卷
关键词:
D O I:
暂无
中图分类号:
学科分类号:
摘要:
A case–control study of five classes of antihypertensive medication used among 2,851 women shows that taking calcium-channel blockers for ≥10 years is associated with increased risk of invasive ductal and lobular breast carcinoma. These results are intriguing, but warrant additional investigation given the study limitations and inconsistent findings in the literature.